INSTAPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INSTAPHARMA
Largest movements
- Receivables within one year -€293,446
down €293,446 (-30.2%), from €970,979 to €677,533
of which Other amounts receivable: -€245,899
- Tangible fixed assets -€95,153
down €95,153 (-10.7%), from €890,330 to €795,178
of which Plant, machinery and equipment: -€80,063
- Intangible fixed assets -€69,399
down €69,399 (-25.2%), from €275,809 to €206,410
- Stocks and contracts +€56,626
up €56,626 (+15.5%), from €364,196 to €420,822
- Other debts -€294,623
down €294,623 (-70.5%), from €417,708 to €123,085
- Debts after one year -€182,328
down €182,328 (-14.4%), from €1.3m to €1.1m
- Trade debts +€59,887
up €59,887 (+14.5%), from €414,207 to €474,093
- Accrued charges and deferred income -€38,183
down €38,183 (-89.7%), from €42,552 to €4,369
- Reserves +€35,893
up €35,893 (+21.7%), from €165,289 to €201,182
of which Distributable reserves: +€35,893
- Gross operating margin +€222,295
up €222,295 (+42.2%), from €526,169 to €748,463
- Staff costs +€73,192
up €73,192 (+27.8%), from €263,110 to €336,301
- Taxes +€8,023
up €8,023 (+114.6%), from €7,001 to €15,025
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,520,965 | €2,123,723 | -€397,243 | -15.8% |
| Fixed assets | 21/28 | €1,166,139 | €1,001,588 | -€164,551 | -14.1% |
| Intangible fixed assets | 21 | €275,809 | €206,410 | -€69,399 | -25.2% |
| Tangible fixed assets | 22/27 | €890,330 | €795,178 | -€95,153 | -10.7% |
| Land and buildings | 22 | €398,608 | €383,524 | -€15,084 | -3.8% |
| Plant, machinery and equipment | 23 | €488,898 | €408,835 | -€80,063 | -16.4% |
| Furniture and vehicles | 24 | €2,824 | €2,818 | -€6 | -0.2% |
| Current assets | 29/58 | €1,354,826 | €1,122,135 | -€232,691 | -17.2% |
| Stocks and contracts in progress | 3 | €364,196 | €420,822 | +€56,626 | +15.5% |
| Stocks | 30/36 | €364,196 | €420,822 | +€56,626 | +15.5% |
| Amounts receivable within one year | 40/41 | €970,979 | €677,533 | -€293,446 | -30.2% |
| Trade receivables | 40 | €236,083 | €188,536 | -€47,547 | -20.1% |
| Other amounts receivable | 41 | €734,896 | €488,997 | -€245,899 | -33.5% |
| Cash at bank and in hand | 54/58 | €19,651 | €21,583 | +€1,932 | +9.8% |
| Deferred charges and accrued income | 490/1 | €0 | €2,197 | +€2,197 | |
| Total equity and liabilities | 10/49 | €2,520,965 | €2,123,723 | -€397,243 | -15.8% |
| Equity | 10/15 | €183,889 | €219,782 | +€35,893 | +19.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €165,289 | €201,182 | +€35,893 | +21.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €163,429 | €199,322 | +€35,893 | +22.0% |
| Amounts payable | 17/49 | €2,337,076 | €1,903,941 | -€433,135 | -18.5% |
| Amounts payable after more than one year | 17 | €1,264,789 | €1,082,461 | -€182,328 | -14.4% |
| Financial debts | 170/4 | €1,264,789 | €1,082,461 | -€182,328 | -14.4% |
| Amounts payable within one year | 42/48 | €1,029,736 | €817,111 | -€212,625 | -20.6% |
| Current portion of amounts payable after more than one year | 42 | €137,367 | €137,004 | -€363 | -0.3% |
| Financial debts | 43 | €45,530 | €49,962 | +€4,432 | +9.7% |
| Credit institutions | 430/8 | €206 | €4,638 | +€4,432 | +2146.7% |
| Other loans | 439 | €45,324 | €45,324 | = | 0.0% |
| Trade debts | 44 | €414,207 | €474,093 | +€59,887 | +14.5% |
| Suppliers | 440/4 | €414,207 | €474,093 | +€59,887 | +14.5% |
| Advances received on contracts in progress | 46 | - | €365 | +€365 | |
| Taxes, remuneration and social security | 45 | €14,924 | €32,602 | +€17,678 | +118.4% |
| Taxes | 450/3 | - | €2,525 | +€2,525 | |
| Remuneration and social security | 454/9 | €14,924 | €30,077 | +€15,153 | +101.5% |
| Other amounts payable | 47/48 | €417,708 | €123,085 | -€294,623 | -70.5% |
| Accrued charges and deferred income | 492/3 | €42,552 | €4,369 | -€38,183 | -89.7% |
| Remuneration, social security and pensions | 62 | €263,110 | €336,301 | +€73,192 | +27.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €199,920 | €195,108 | -€4,812 | -2.4% |
| Other operating charges | 640/8 | €1,190 | €1,183 | -€7 | -0.6% |
| Gross operating margin | 9900 | €526,169 | €748,463 | +€222,295 | +42.2% |
| Operating profit (loss) | 9901 | €61,949 | €215,871 | +€153,921 | +248.5% |
| Financial income | 75/76B | €0 | €29 | +€29 | |
| Recurring financial income | 75 | €0 | €29 | +€29 | |
| Financial charges | 65/66B | €45,656 | €44,983 | -€673 | -1.5% |
| Recurring financial charges | 65 | €45,656 | €44,983 | -€673 | -1.5% |
| Profit (loss) for the period before taxes | 9903 | €16,294 | €170,918 | +€154,624 | +949.0% |
| Income taxes | 67/77 | €7,001 | €15,025 | +€8,023 | +114.6% |
| Profit (loss) for the period | 9904 | €9,292 | €155,893 | +€146,600 | +1577.6% |
| Profit (loss) for the period to be appropriated | 9905 | €9,292 | €155,893 | +€146,600 | +1577.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.